| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.09B | 52.01B | 51.12B | 51.62B | 47.65B | 44.03B |
| Gross Profit | 5.62B | 5.56B | 5.84B | 5.09B | 5.24B | 4.47B |
| EBITDA | 4.71B | 5.23B | 5.28B | 4.49B | 4.67B | 3.87B |
| Net Income | 2.21B | 2.21B | 2.27B | 1.77B | 1.95B | 1.50B |
Balance Sheet | ||||||
| Total Assets | 47.34B | 47.48B | 46.73B | 42.31B | 41.25B | 40.83B |
| Cash, Cash Equivalents and Short-Term Investments | 13.97B | 13.95B | 12.24B | 9.45B | 8.27B | 7.99B |
| Total Debt | 6.64B | 7.00B | 8.15B | 7.14B | 8.11B | 9.02B |
| Total Liabilities | 21.00B | 21.71B | 22.70B | 20.27B | 20.68B | 21.69B |
| Stockholders Equity | 26.34B | 25.77B | 24.02B | 22.03B | 20.55B | 19.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.70B | -208.00M | 2.03B | 2.62B | 2.62B |
| Operating Cash Flow | 0.00 | 3.80B | 4.58B | 3.58B | 3.80B | 3.61B |
| Investing Cash Flow | 0.00 | -1.13B | -3.14B | -1.25B | -1.94B | -1.01B |
| Financing Cash Flow | 0.00 | -1.76B | 610.00M | -1.40B | -1.30B | -1.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥113.40B | 35.08 | ― | 3.57% | 3.00% | 5.43% | |
73 Outperform | ¥19.41B | 6.47 | ― | 2.46% | 0.21% | 0.95% | |
72 Outperform | ¥223.44B | 3.64 | 4.72% | 1.66% | 5.50% | -26.63% | |
69 Neutral | ¥6.05B | 9.76 | ― | 1.62% | 8.03% | 67.38% | |
64 Neutral | ¥366.10B | 11.50 | 5.53% | 4.35% | 22.07% | 86.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥591.75B | 5.81 | 7.44% | 2.10% | 5.58% | 114.23% |